Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Anticoagulation for Splanchnic Vein Thrombosis in Patients with Myeloproliferative Neoplasms: A Systematic Review and Meta-Analysis

Pavlina Chrysafi, Kevin Barnum, Genevieve Gerhard, Thita Chiasakul, Arshit Narang, Megan McNichol, Nicoletta Riva, Walter Ageno, Jeffrey I. Zwicker, Rushad Patell

Blood (2023) 142 (Supplement 1): 1817.

https://doi.org/10.1182/blood-2023-182699

Published: 2023

Journal Articles

Pediatric Splanchnic Vein Thrombosis: Systematic Review and Meta-Analysis

Sarina Levy-Mendelovich, Shelly Soffer, Eyal Klang, Assaf Arie Barg, Walter Ageno, Gili Kenet, Omri Cohen

Blood (2022) 140 (Supplement 1): 5690–5691.

https://doi.org/10.1182/blood-2022-165236

Published: 2022

Journal Articles

Treatment of Portal, Mesenteric, and Splenic Vein Thrombosis with Rivaroxaban: A Pilot, Prospective Cohort Study

Blood (2021) 138 (Supplement 1): 671.

https://doi.org/10.1182/blood-2021-153813

Published: 2021

Journal Articles

Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis

Emanuele Valeriani, Marcello Di Nisio, Nicoletta Riva, Omri Cohen, Juan-Carlos Garcia-Pagan, Marta Magaz, Ettore Porreca, Walter Ageno

Blood (2021) 137 (9): 1233–1240.

https://doi.org/10.1182/blood.2020006827

Published: 2021

Includes: Supplemental data

Journal Articles

Association of Bleeding Severity with Mortality with Extended Thromboprophylaxis in the Medically Ill in the Mariner Trial

Alex C. Spyropoulos, MD, Walter Ageno, Gregory W. Albers, MD, C. Gregory Elliott, MD, Jonathan L. Halperin, MD, William R. Hiatt, Gregory Maynard, MD, P. Gabriel Steg, MD, Jeffrey I. Weitz, MD, Theodore E. Spiro, MD, Wentao Lu, PhD, Chiara Sugarmann, BSN, MSHS, Concetta Lipardi, MD PhD, Gary E. Raskob, PhD, Elliot S. Barnathan, MD

Blood (2019) 134 (Supplement_1): 3669.

https://doi.org/10.1182/blood-2019-122621

Published: 2019

Journal Articles

Association of Bleeding Severity with Mortality with in-Hospital and Extended Thromboprophylaxis in the Medically Ill in the Magellan Trial

Alex C. Spyropoulos, MD, Gary E. Raskob, PhD, Alexander T Cohen, MBBS, MSc, MD, Walter Ageno, Jeffrey I. Weitz, MD, Theodore E. Spiro, MD, Wentao Lu, PhD, Concetta Lipardi, MD PhD, Elliot S. Barnathan, MD

Blood (2019) 134 (Supplement_1): 2441.

https://doi.org/10.1182/blood-2019-122930

Published: 2019

Journal Articles

Increased Risk of Death in Acutely Ill Medical Patients with Asymptomatic Proximal Deep Vein Thrombosis or Symptomatic Venous Thromboembolism: Insights from the Magellan Study

Gary E. Raskob, PhD, Alex C. Spyropoulos, MD, Alexander T Cohen, MBBS, MSc, MD, Jeffrey I. Weitz, MD, Walter Ageno, Yoriko De Sanctis, MS, Wentao Lu, PhD, Jianfeng Xu, PhD, John Albanese, BS, MBA, Chiara Sugarmann, BSN, MSHS, Concetta Lipardi, MD PhD, Theodore E. Spiro, MD, Elliot S. Barnathan, MD

Blood (2019) 134 (Supplement_1): 163.

https://doi.org/10.1182/blood-2019-122934

Published: 2019

Journal Articles

A Pooled Analysis of the Xalia and Xalia-Lea Non-Interventional Studies of Rivaroxaban Versus Standard Anticoagulation in Venous Thromboembolism

Alexander G. G. Turpie, MD, Lorenzo G Mantovani, Sylvia Katharina Haas, MD PhD, Reinhold Kreutz, PhD, Danja Monje, Jonas Schneider, Martin van Eickels, Miriam Tamm, Martin Gebel, Walter Ageno

Blood (2017) 130 (Supplement 1): 2386.

https://doi.org/10.1182/blood.V130.Suppl_1.2386.2386

Published: 2017

Journal Articles

An Individual Participant Data Meta-Analysis of 13 Randomized Trials to Evaluate the Impact of Prophylactic Use of Heparin in Oncological Patients

Blood (2017) 130 (Supplement 1): 626.

https://doi.org/10.1182/blood.V130.Suppl_1.626.626

Published: 2017

Journal Articles

The Khorana Score for the Prediction of Venous Thromboembolism in Patients with Solid Cancer: An Individual Patient Data Meta-Analysis

Blood (2017) 130 (Supplement 1): 627.

https://doi.org/10.1182/blood.V130.Suppl_1.627.627

Published: 2017

Journal Articles

Subgroup Analysis of Patients with Cancer in Xalia - a Non-Interventional Study of Rivaroxaban in Routine Treatment of Deep Vein Thrombosis

Alexander G G Turpie, MD, Lorenzo G Mantovani, Sylvia Haas, Reinhold Kreutz, Danja Monje, Jonas Schneider, Martin van Eickels, Martin Gebel, Walter Ageno

Blood (2016) 128 (22): 1438.

https://doi.org/10.1182/blood.V128.22.1438.1438

Published: 2016

Journal Articles

Xalia, a Non-Interventional Study Comparing Rivaroxaban with Standard Anticoagulation for Initial and Long-Term Therapy in Deep Vein Thrombosis

Alexander G G Turpie, MD, Lorenzo G Mantovani, Sylvia Haas, Reinhold Kreutz, Danja Monje, Jonas Schneider, Martin van Eickels, Martin Gebel, Walter Ageno

Blood (2015) 126 (23): 894.

https://doi.org/10.1182/blood.V126.23.894.894

Published: 2015

Journal Articles

Small clots with large impact

Jan Beyer-Westendorf, Walter Ageno

Blood (2015) 126 (8): 926–927.

https://doi.org/10.1182/blood-2015-07-653394

Published: 2015

Journal Articles

The role of thrombolytic therapy in pulmonary embolism

Tzu-Fei Wang, Alessandro Squizzato, Francesco Dentali, Walter Ageno

Blood (2015) 125 (14): 2191–2199.

https://doi.org/10.1182/blood-2014-08-559278

Published: 2015

Includes: Supplemental data

Journal Articles

How I treat splanchnic vein thrombosis

Walter Ageno, Francesco Dentali, Alessandro Squizzato

Blood (2014) 124 (25): 3685–3691.

https://doi.org/10.1182/blood-2014-07-551515

Published: 2014

Journal Articles

Safety of Vitamin K Antagonist Treatment for Splanchnic Vein Thrombosis: A Multicenter Retrospective Cohort Study

Riva Nicoletta, Alberto Tosetto, MD, Walter Ageno, MD, Daniela Poli, MD, Sophie Testa, MD, Serena Rupoli, MD, Rita Santoro, Francesco Rodeghiero

Blood (2014) 124 (21): 4276.

https://doi.org/10.1182/blood.V124.21.4276.4276

Published: 2014

Journal Articles

Arterial and Venous Thrombosis: Clinical Evidence for Mechanistic Overlap

Walter Ageno, MD

Blood (2014) 124 (21): SCI-3.

https://doi.org/10.1182/blood.V124.21.SCI-3.SCI-3

Published: 2014

Journal Articles

Antithrombotic Treatment and Outcomes of Splanchnic Vein Thrombosis in an International Prospective Registry: Results of 2-Year Follow-up

Walter Ageno, MD, Nicoletta Riva, Sam Schulman, MD PhD, Jan Beyer-Westendorf, MD, Soo-Mee Bang, Marco Senzolo, Elvira Grandone, Giovanni Barillari, Matteo Di Minno, Rita Duce, Alessandra Malato, Rita Santoro, Daniela Poli, Peter Verhamme, MD PhD, Ida Martinelli, Pieter W. Kamphuisen, MD PhD, Francesco Dentali, MD

Blood (2014) 124 (21): 592.

https://doi.org/10.1182/blood.V124.21.592.592

Published: 2014

Journal Articles

Analysis Of Warfarin Drug-Drug Interactions With Antibiotics In The Ambulatory Care Setting

Nathan P Clark, PharmD, FCCP, BCPS, Thomas Delate, PhD, MS, Catherine S Riggs, PharmD, Daniel M Witt, PharmD, FCCP, BCPS, Elaine M Hylek, MD, David A Garcia, MD, Walter Ageno, MD, Francesco Dentali, MD, Mark A. Crowther, MD, MSc, FRCPC

Blood (2013) 122 (21): 1143.

https://doi.org/10.1182/blood.V122.21.1143.1143

Published: 2013

Journal Articles

Antithrombotic Treatment of Splanchnic Vein Thrombosis: Results of an International Registry

Blood (2012) 120 (21): 499.

https://doi.org/10.1182/blood.V120.21.499.499

Published: 2012

NARROW

Anticoagulation for Splanchnic Vein Thrombosis in Patients with Myeloproliferative Neoplasms: A Systematic Review and Meta-Analysis

Pediatric Splanchnic Vein Thrombosis: Systematic Review and Meta-Analysis

Treatment of Portal, Mesenteric, and Splenic Vein Thrombosis with Rivaroxaban: A Pilot, Prospective Cohort Study

Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis

Association of Bleeding Severity with Mortality with Extended Thromboprophylaxis in the Medically Ill in the Mariner Trial

Association of Bleeding Severity with Mortality with in-Hospital and Extended Thromboprophylaxis in the Medically Ill in the Magellan Trial

Increased Risk of Death in Acutely Ill Medical Patients with Asymptomatic Proximal Deep Vein Thrombosis or Symptomatic Venous Thromboembolism: Insights from the Magellan Study

A Pooled Analysis of the Xalia and Xalia-Lea Non-Interventional Studies of Rivaroxaban Versus Standard Anticoagulation in Venous Thromboembolism

An Individual Participant Data Meta-Analysis of 13 Randomized Trials to Evaluate the Impact of Prophylactic Use of Heparin in Oncological Patients

The Khorana Score for the Prediction of Venous Thromboembolism in Patients with Solid Cancer: An Individual Patient Data Meta-Analysis

Subgroup Analysis of Patients with Cancer in Xalia - a Non-Interventional Study of Rivaroxaban in Routine Treatment of Deep Vein Thrombosis

Xalia, a Non-Interventional Study Comparing Rivaroxaban with Standard Anticoagulation for Initial and Long-Term Therapy in Deep Vein Thrombosis

Small clots with large impact

The role of thrombolytic therapy in pulmonary embolism

How I treat splanchnic vein thrombosis

Safety of Vitamin K Antagonist Treatment for Splanchnic Vein Thrombosis: A Multicenter Retrospective Cohort Study

Arterial and Venous Thrombosis: Clinical Evidence for Mechanistic Overlap

Antithrombotic Treatment and Outcomes of Splanchnic Vein Thrombosis in an International Prospective Registry: Results of 2-Year Follow-up

Analysis Of Warfarin Drug-Drug Interactions With Antibiotics In The Ambulatory Care Setting

Antithrombotic Treatment of Splanchnic Vein Thrombosis: Results of an International Registry

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only